After excluding the Van Hemelrijck et al. study [36] which did not use high-sensitivity CRP measurements, the association of high-sensitivity CRP with lung cancer risk was somewhat stronger (RR 1.33, 95% CI 1.23–1.45; P = 0.346, I2 = 10.6%). Here, CRP is linked to lung carcinoma.